JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
4D Molecular Therapeutics
FDMT
$755M
| $4.57M | ﹤0.01% |
820,069
+504,086
| +160% | +$3.96M |
2021 Q1
15 quarters
|
|
3327
CNB Financial Corp
CCNE
$1.01B
| $4.57M | ﹤0.01% |
183,675
+27,874
| +18% | +$727K |
2017 Q4
28 quarters
|
|
3328
Mitsubishi UFJ Financial
MUFG
$257B
| $4.57M | ﹤0.01% |
389,603
+131,305
| +51% | +$1.48M |
2013 Q2
46 quarters
|
|
3329
Yext
YEXT
$644M
| $4.56M | ﹤0.01% |
716,693
+201,472
| +39% | +$1.46M |
2017 Q4
28 quarters
|
|
3330
The RealReal
REAL
$1.08B
| $4.56M | ﹤0.01% |
417,030
-321,589
| -44% | -$1.71M |
2019 Q2
22 quarters
|
|
3331
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.75B
| $4.55M | ﹤0.01% |
104,158
+2,023
| +2% | +$88.8K |
2014 Q1
43 quarters
|
|
|
HUCK
3332
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$151M
| $4.55M | ﹤0.01% |
643,062
+118,957
| +23% | +$963K |
2018 Q2
26 quarters
|
|
3333
CALL
Dollar General
DG
$26.2B
| $4.55M | ﹤0.01% |
60,000
| – | – |
2021 Q3
13 quarters
|
|
|
SKE
3334
Skeena Resources
SKE
$3.76B
| $4.55M | ﹤0.01% |
+521,630
| New | +$4.75M |
2024 Q4
0 quarters
|
|
3335
United Parks & Resorts
PRKS
$1.47B
| $4.55M | ﹤0.01% |
80,924
-578,501
| -88% | -$31.7M |
2015 Q4
36 quarters
|
|
3336
CALL
Ferrari
RACE
$68.1B
| $4.55M | ﹤0.01% |
10,700
-15,200
| -59% | -$6.86M |
2024 Q1
3 quarters
|
|
3337
Denali Therapeutics
DNLI
$3.2B
| $4.54M | ﹤0.01% |
222,983
-12,403
| -5% | -$318K |
2018 Q1
27 quarters
|
|
3338
Protolabs
PRLB
$2.35B
| $4.54M | ﹤0.01% |
116,105
-23,785
| -17% | -$855K |
2016 Q2
34 quarters
|
|
3339
Integra LifeSciences
IART
$986M
| $4.53M | ﹤0.01% |
199,691
+113,061
| +131% | +$2.47M |
2014 Q4
40 quarters
|
|
3340
CALL
Rocket Lab Corp
RKLB
$47.3B
| $4.53M | ﹤0.01% |
177,700
| – | – |
2024 Q1
3 quarters
|
|
3341
iShares MSCI Indonesia ETF
EIDO
$423M
| $4.52M | ﹤0.01% |
244,484
-405,637
| -62% | -$8.38M |
2022 Q1
11 quarters
|
|
3342
Adecoagro
AGRO
$1.46B
| $4.5M | ﹤0.01% |
477,552
-162,417
| -25% | -$1.77M |
2020 Q2
18 quarters
|
|
3343
Origin Bancorp
OBK
$1.65B
| $4.5M | ﹤0.01% |
135,115
+62,129
| +85% | +$2.08M |
2018 Q2
26 quarters
|
|
|
MLNK
3344
DELISTED
MeridianLink
MLNK
| $4.47M | ﹤0.01% |
216,566
+195,333
| +920% | +$4.3M |
2021 Q3
13 quarters
|
|
3345
Freedom Holding
FRHC
$11B
| $4.47M | ﹤0.01% |
34,213
+25,350
| +286% | +$2.91M |
2020 Q2
18 quarters
|
|
3346
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $4.47M | ﹤0.01% |
184,795
-185,225
| -50% | -$4.53M |
2016 Q2
34 quarters
|
|
3347
NB Bancorp
NBBK
$989M
| $4.47M | ﹤0.01% |
247,482
+47,678
| +24% | +$916K |
2024 Q1
3 quarters
|
|
3348
JPMorgan Healthcare Leaders ETF
JDOC
$8.93M
| $4.46M | ﹤0.01% |
88,196
| – | – |
2023 Q4
4 quarters
|
|
3349
Mitek Systems
MITK
$801M
| $4.45M | ﹤0.01% |
399,905
+136,949
| +52% | +$1.28M |
2017 Q3
29 quarters
|
|
|
PARA
3350
PUT
DELISTED
Paramount Global Class B
PARA
| $4.45M | ﹤0.01% |
425,500
-251,000
| -37% | -$2.7M |
2022 Q1
11 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.